Lawes CMM, Hoorn SV, Rodgers A. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.

Article  PubMed  Google Scholar 

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease; results from the AASK trial. JAMA 2002;288:2421–31.

Article  CAS  PubMed  Google Scholar 

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–916.

Article  CAS  PubMed  Google Scholar 

Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, et al. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation. 2007;116:984–92.

Article  CAS  PubMed  Google Scholar 

Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med. 2008;14:1370–6.

Article  CAS  PubMed  Google Scholar 

Berger S, Bleich M, Schmid W, Greger R, Schütz G. Mineralocorticoid receptor knockout mice: lessons on Na+ metabolism. Kidney Int. 2000;57:1295–8.

Article  CAS  PubMed  Google Scholar 

Ikemoto M, Morimoto S, Ichihara A. Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism. Hypertens Res. 2024. https://doi.org/10.1038/s41440-024-01651-5

Article  PubMed  Google Scholar 

Mente A, O’Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388:465–75.

Article  CAS  PubMed  Google Scholar 

He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and asian mild hypertensives. Hypertension. 2009;54:482–8.

Article  CAS  PubMed  Google Scholar 

Zhou TL, Henry RMA, Stehouwer CDA, Sloten TTV, Reesink KD, Kroon AA. Blood pressure variability, arterial stiffness, and arterial remodeling. Hypertension. 2018;72:1002–10.

Article  CAS  PubMed  Google Scholar 

Diaz KM, Muntner P, Levitan EB, Brown MD, Babbitt DM, Shimbo D. The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial. J Hypertens. 2014;32:840–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takashima N, Ohkubo T, Miura K, Okayama A, Okuda N, Nakagawa H, et al. Factors associated with intra-individual visit-to-visit variability of blood pressure in four countries: the INTERMAP study. J Hum Hypertens. 2019;33:229–36.

Article  CAS  PubMed  Google Scholar 

Kotchen TA, Luke RG, Ott CE, Galla JH, Whitescarver S. Effect of chloride on renin and blood pressure responses to sodium chloride. Ann Intern Med. 1983;98:817–22.

Article  CAS  PubMed  Google Scholar 

Schorr U, Distler A, Sharma AM. Effect of sodium chloride- and sodium bicarbonate-rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: a randomized double-blind crossover trial. J Hypertens. 1996;14:131–5.

CAS  PubMed  Google Scholar